ClinicalTrials.gg
Not yet recruitingNCT07800078LactogameUpdated Sep 2, 2026

Evaluation of a Wearable Technology to Support Breastfeeding Women

An interventional study of Breast Milk-Sensitive Wearable Technology in Breastfeeding, sponsored by Özlem Ülkü BULUT. Not yet recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-02.

Sponsored by Özlem Ülkü BULUT · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Not applicable
Ages
18 Years to 45 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 274 studies in Breast Feeding with a site in Turkey — 68 open to participants now, 77 under way, none of them phase 3. Breast Feeding · Turkey.

Planned enrollment
244th of 252
36 · median 80
Started
2026
with 32 others
No phase
251 of 274
65 open now
Primary completion
2026-12
later than 59 of 76 live
Registered
267th of 274
by date

Among the 274 studies in Breast Feeding with a site in Turkey, this one is the 244th largest by planned enrollment of the 252 interventional ones, is one of 33 that started in 2026, is one of 251 with no phase, reaches primary completion later than 59 of the 76 other live ones, and was the 267th registered.

By phase

274 studies; the count open now beside each. This study's row is marked.

No phasethis study251 · 65 open
Observational22 · 3 open
Phase 41 · 0 open

By the year they started

First in 2011; this study’s year is marked. 33 started in 2026.

What they test

Size and results

Median enrollment 80 across the 252 interventional studies, 163 across the 22 observational. Of the 178 that completed or were terminated, 0 (0%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 274 studies in Breast Feeding with a site in Turkey, or all of them as a file.
02

Study summary

This study aims to evaluate a wearable technology developed to support breastfeeding women. The study will assess the performance of sensors in the wearable prototype for monitoring breast milk fullness and milk flow and compare the sensor measurements with the amount of breast milk obtained through breast pumping. The study will also evaluate women's experiences, satisfaction, perceived usefulness, and ease of use of the wearable prototype and its mobile application. The technology is intended for monitoring and support purposes and will not be used for diagnosis, treatment, or clinical decision-making.

03

Conditions studied

  • Breastfeeding

Browse trials for

Keywords

  • Wearable Technology
  • Breast Milk
  • Breastfeeding Support
  • Digital Health
  • Milk Flow
  • User Experience
04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Women aged 18-45 years
  • Currently breastfeeding
  • Having an infant aged 0-6 months
  • Willing to use the wearable technology and accompanying mobile application for 15 days
  • Able to express breast milk for comparison with sensor measurements
  • Voluntarily agreeing to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Having a medical condition that prevents breastfeeding or breast milk expression
  • Having an active breast or nipple condition that prevents the use of the wearable prototype
  • Being unable to use the wearable technology or mobile application during the study period
  • Withdrawing consent at any stage of the study
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Wearable Breastfeeding Support Technology

    Participants will use the wearable prototype and its accompanying mobile application. Sensor measurements obtained during use will be evaluated and compared with the amount of breast milk obtained through breast pumping. Participants' experiences with the technology will also be assessed.

    Device: Breast Milk-Sensitive Wearable Technology

Interventions

  • DeviceBreast Milk-Sensitive Wearable Technology

    Participants will use a breast milk-sensitive wearable prototype integrated with a mobile application. The wearable technology collects sensor-based measurements related to breast milk fullness and milk flow. Sensor measurements will be compared with the amount of breast milk obtained through breast pumping. Participants' experiences, satisfaction, perceived usefulness, and ease of use of the wearable technology and mobile application will also be evaluated.

06

What researchers measure

Primary outcomes

  1. Electrical Sensor Signals Obtained From the Wearable Prototype

    The wearable sensor system will acquire and analyze sensor signals to generate a Breast Milk Fullness Index ranging from 0 to 100. Higher values indicate greater estimated breast milk fullness. Measurements will be obtained in relation to breastfeeding and/or breast pumping sessions and compared with reference measurements of milk removal.

    Time frame: During the 15-day intervention period

  2. Milk Flow Pattern Parameters Measured by the Wearable Sensor System

    Milk flow-related signal patterns will be acquired and analyzed by the LactoGame wearable sensor system during breastfeeding and/or breast pumping. Quantitative system-derived parameters, including average and peak signal characteristics, will be used to characterize milk flow patterns.

    Time frame: During the 15-day intervention period

  3. Expressed Breast Milk Volume Assessed Using the Breast Milk Expression Volume Record Form

    Expressed breast milk volume will be recorded using the Breast Milk Expression Volume Record Form. For each pumping session, the amount of breast milk obtained will be recorded in milliliters (mL), together with breast side, expression method, and expression duration. Expressed milk volume will be used as a reference measurement for comparison with sensor-derived measurements.

    Time frame: During the 15-day intervention period

Secondary outcomes

  1. User Experience and Satisfaction Assessed Using the User Experience and Satisfaction Evaluation Form

    User experience and satisfaction will be assessed using the researcher-developed 14-item User Experience and Satisfaction Evaluation Form. Each item is rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). Total scores range from 14 to 70, with higher scores indicating a more positive user experience and greater satisfaction with the wearable prototype and mobile application. The form also includes three open-ended questions to obtain additional qualitative feedback.

    Time frame: At the end of the 15-day intervention period

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.

Of 502 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 2 months is below that.

Counting every sponsor, half of 510 studies reached it within 12 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 25, 2026
First posted
Sep 2, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Dec 1, 2026
CompletionEst.
Sep 1, 2027
Last update
Sep 2, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 2, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07800078
Lead sponsor
Özlem Ülkü BULUT
Collaborators
Lokman Hekim University
Responsible party
Özlem Ülkü BULUT (Assistant Profesor, Lokman Hekim University) — Sponsor-investigator
First posted
Sep 2, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Dec 1, 2026 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Sep 2, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion